Syqe Medical completed a $50 million funding round, led by Jerusalem-based investment firm Shavit Capital and participated by PRM Holdings, the investment arm of German botanical product company Martin Bauer Group and another “global strategic player in the field of pharmaceuticals".
Syqe Medical, located in Israel, is developing a system for analyzing information collected from a plurality of users in conjunction with the use of delivery devices for active agents. Their system's design is geared towards inhaler devices for cannabis.
Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.
View Patent Forecast®
Top Corporations
News and Insights
Data Visualization
Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.